Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03021161Phase 4Unknown
Phase 4, randomised, double-blind trial in occupational asthma (OA), sponsored by Universidade de São Paulo. Primary endpoint: Allergic Sensitization at 2 years. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03021161.